Elsukova O.S., Nikitina E.A., Chuprova A.V., Kaysina O.A.
Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice
|
№2 / 2024
|
D.V. Ivashchenko, A.Yu. Kravchenko, S.Z. Khoang, N.I. Buromskaya, P.V. Shimanov, R.V. Deitch, M.I. Nastovich, K.A. Akmalova, A.A Kachanova, L.M. Savchenko, Yu.S. Shevchenko, D.A. Sychev
Pharmacogenetic factors of haloperidol’s safety in adolescents experiencing acute psychotic episodes
|
№4-5 / 2023
|
L.S. Kruglova (1), A.A. Khotko (2), N.S. Rudneva (3)
Are the goals of psoriasis treatment achievable in real clinical practice?
|
№14 / 2021
|
L.S. Kruglova (1), N.S. Tataurschikova (2), E.V. Tipaeva (3)
Issues of long-term use of antihistamines
|
№14 / 2021
|
D.V. Ivashchenko (1, 2), N.I. Buromskaya (3), P.V. Shimanov (3), R.V. Deich (3), I.V. Dorina (3), M.I. Nastovich (3), K.A. Akmalova (1), A.A. Kachanova (1), E.A. Grishina (1), L.M. Savchenko (1), Yu.S. Shevchenko (1), D.A. Sychev (1)
Pharmacogenetic predictors of the efficacy and safety of antipsychotics in adolescents with an acute psychotic episode
|
№11 / 2021
|
A.S. Kulakova, D.L. Bentsion, V.G. Elishev, V.A. Vetrov
Systemic alpha-radiotherapy with radium-223 (Xofigo) in patients with metastatic castration-resistant prostate cancer (mCRPC). Clinical experience of using the drug in Sverdlovsk Regional Oncological Dispensary, Yekaterinburg
|
№11 / 2021
|
D.N. Andreev, I.V. Mayev, A.A. Samsonov, E.G. Lobanova, E.V. Partsvania-Vinogradova
SAFETY OF ERADICATION THERAPY OF HELICOBACTER PYLORI INFECTION: SYSTEMATIZATION OF LITERATURE DATA
|
№13 / 2017
|
G.L.Yurenev, D.N. Andreev, E.V. Partsvaniya-Vinogradova, D.T. Dicheva
HYBRID SCHEME OF ERADICATION THERAPY OF HELICOBACTER PYLORI INFECTION: SYSTEMATIZATION OF LITERATURE DATA
|
№2 / 2017
|
N.E. Komleva (1), A.A. Maryanovsky (2), I.V. Zaikina (1)
THERAPY OF GERD: POSSIBILITIES OF OPTIMIZATION AND IMPROVEMENT OF THE EFFECTIVENESS
|
№19 / 2016
|
N.A. Shostak, A.A. Klimenko, D.A. Anichkov, A.A. Kondrashov
NEW MECHANISMS OF ACTION OF NSAIDS: FOCUS ON CARDIOVASCULAR SAFETY
|
№19 / 2016
|
A.V. Schulkin
MEXIDOL: MODERN ASPECTS OF THE PHARMACOKINETICS AND PHARMACODYNAMICS
|
№s4-16 / 2016
|
E.V. Ivanova (1), E.A. Mezhevitinova (2), A.E. Donnikov (2), I.G. Nikitin (3), V.N. Prilepskaya (2)
PHARMACOGENETIC ASPECTS OF COMBINED HORMONAL CONTRACEPTION
|
№3 / 2016
|